Measurement and Enhancement of Innovation Resilience in Hunan Biomedical Industry

生物医药产业是关乎国计民生的特殊高技术产业。基于创新韧性的核心要义和生物医药产业的特定属性，构建了其创新韧性的评价指标体系，并运用熵值法测算了2015~2023年间湖南生物医药产业的创新韧性水平。研究发现：2015~2023年湖南生物医药产业规模快速扩大，但其创新韧性的整体水平上升幅度较小。未来湖南省须紧抓全球生物医药产业跨越发展的机遇期，持续增强该产业的创新活力和创新韧性，并主要着力于优化生物医药产业的创新组织网络、聚焦生物医药产业关键核心技术的研发、完善科技人才的“引育留用”全链条、引领生物医药产业数字化转型升级等方面。The biopharmaceutical industry is a special high-tech industry that concerns the national economy and people’s livelihood. Based on the core essence of innovation resilience and the specific attributes of the biopharmaceutical industry, an evaluation index system for its innovation resilience was constructed, and the entropy method was used to measure the innovation resilience level of Hunan’s biopharmaceutical industry from 2015 to 2023. Research has found that the overall level of innovation resilience in Hunan’s biopharmaceutical industry has improved between 2015 and 2023, but the increase is not significant. In the future, Hunan Province needs to seize the strategic development opportunities of the biopharmaceutical industry, and the key is to continuously enhance its innovation vitality. The paper concludes that the improvement of innovation resilience in Hunan’s biopharmaceutical industry must focus on optimizing the innovation organizational network of biopharmaceutical enterprises, focusing on the research and development of key core technologies in the biopharmaceutical industry, improving the full chain of “attraction, training, retention and utilization” of scientific and technological talents, and leading the digital transformation and upgrading of the biopharmaceutical industry.